23510463|t|Targeting erythropoietin for chronic neurodegenerative diseases.
23510463|a|INTRODUCTION: Since erythropoietin (EPO) and EPO receptor (EPOR) are expressed in the central nervous system (CNS) beyond hematopoietic system, EPO illustrates a robust biological function in maintaining neuronal survival and regulating neurogenesis and may play a crucial role in neurodegenerative diseases. AREAS COVERED: EPO is capable of modulating multiple cellular signal transduction pathways to promote neuronal survival and enhance the proliferation and differentiation of neuronal progenitor cells. Initially, EPO binds to EPOR to activate the Janus-tyrosine kinase 2 (Jak2) protein followed by modulation of protein kinase B (Akt), mammalian target of rapamycin, signal transducer and activators of transcription 5, mitogen-activated protein kinases, protein tyrosine phosphatases, Wnt1 and nuclear factor kappaB. As a result, EPO may actively prevent the progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis and motor neuron diseases. EXPERT OPINION: Novel knowledge of the cell signaling pathways regulated by EPO in the CNS will allow us to establish the foundation for the development of therapeutic strategies against neurodegenerative diseases. Further investigation of the role of EPO in neurodegenerative diseases can not only formulate EPO as a therapeutic candidate, but also further identify novel therapeutic targets for these disorders.
23510463	10	24	erythropoietin	Gene	2056
23510463	37	63	neurodegenerative diseases	Disease	MESH:D019636
23510463	85	99	erythropoietin	Gene	2056
23510463	101	104	EPO	Gene	2056
23510463	110	122	EPO receptor	Gene	2057
23510463	124	128	EPOR	Gene	2057
23510463	209	212	EPO	Gene	2056
23510463	346	372	neurodegenerative diseases	Disease	MESH:D019636
23510463	389	392	EPO	Gene	2056
23510463	585	588	EPO	Gene	2056
23510463	598	602	EPOR	Gene	2057
23510463	619	642	Janus-tyrosine kinase 2	Gene	3717
23510463	644	648	Jak2	Gene	3717
23510463	684	700	protein kinase B	Gene	2185
23510463	702	705	Akt	Gene	207
23510463	708	737	mammalian target of rapamycin	Gene	2475
23510463	858	862	Wnt1	Gene	7471
23510463	903	906	EPO	Gene	2056
23510463	947	973	neurodegenerative diseases	Disease	MESH:D019636
23510463	985	1004	Alzheimer's disease	Disease	MESH:D000544
23510463	1006	1025	Parkinson's disease	Disease	MESH:D010300
23510463	1027	1035	epilepsy	Disease	MESH:D004827
23510463	1037	1055	multiple sclerosis	Disease	MESH:D009103
23510463	1060	1081	motor neuron diseases	Disease	MESH:D016472
23510463	1159	1162	EPO	Gene	2056
23510463	1270	1296	neurodegenerative diseases	Disease	MESH:D019636
23510463	1335	1338	EPO	Gene	2056
23510463	1342	1368	neurodegenerative diseases	Disease	MESH:D019636
23510463	1392	1395	EPO	Gene	2056
23510463	Negative_Correlation	MESH:D010300	2056
23510463	Negative_Correlation	MESH:D016472	2056
23510463	Association	2056	2185
23510463	Positive_Correlation	2057	3717
23510463	Association	2056	207
23510463	Association	2056	7471
23510463	Association	2056	2475
23510463	Negative_Correlation	MESH:D004827	2056
23510463	Association	MESH:D019636	2056
23510463	Bind	2056	2057
23510463	Negative_Correlation	MESH:D009103	2056
23510463	Positive_Correlation	2056	3717
23510463	Negative_Correlation	MESH:D000544	2056

